European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer
- PMID: 33626377
- DOI: 10.1016/j.annonc.2021.01.006
European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer
Abstract
Background: We predicted cancer mortality statistics for 2021 for the European Union (EU) and its five most populous countries plus the UK. We also focused on pancreatic cancer and female lung cancer.
Materials and methods: We obtained cancer death certifications and population data from the World Health Organization and Eurostat databases for 1970-2015. We predicted numbers of deaths and age-standardised (world population) rates for 2021 for total cancers and 10 major cancer sites, using a joinpoint regression model. We calculated the number of avoided deaths over the period 1989-2021.
Results: We predicted 1 267 000 cancer deaths for 2021 in the EU, corresponding to age-standardised rates of 130.4/100 000 men (-6.6% since 2015) and 81.0/100 000 for women (-4.5%). We estimated further falls in male lung cancer rates, but still trending upward in women by +6.5%, reaching 14.5/100 000 in 2021. The breast cancer predicted rate in the EU was 13.3/100 000 (-7.8%). The rates for stomach and leukaemias in both sexes and for bladder in males are predicted to fall by >10%; trends for other cancer sites were also favourable, except for the pancreas, which showed stable patterns in both sexes, with predicted rates of 8.1/100 000 in men and 5.6/100 000 in women. Rates for pancreatic cancer in EU men aged 25-49 and 50-64 years declined, respectively, by 10% and 1.8%, while for those aged 65+ years increased by 1.3%. Rates fell for young women only (-3.4%). Over 1989-2021, about 5 million cancer deaths were avoided in the EU27 compared with peak rates in 1988.
Conclusion: Overall cancer mortality continues to fall in both sexes. However, specific focus is needed on pancreatic cancer, which shows a sizeable decline for young men only. Tobacco control remains a priority for the prevention of pancreatic and other tobacco-related cancers, which account for one-third of the total EU cancer deaths, especially in women, who showed less favourable trends.
Keywords: Brexit; Europe; cancer; mortality rates; pancreatic cancer; prediction models.
Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Disclosure The authors have declared no conflicts of interest.
Similar articles
-
European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?Ann Oncol. 2015 Apr;26(4):779-786. doi: 10.1093/annonc/mdv001. Epub 2015 Jan 26. Ann Oncol. 2015. PMID: 25623049
-
European cancer mortality predictions for the year 2023 with focus on lung cancer.Ann Oncol. 2023 Apr;34(4):410-419. doi: 10.1016/j.annonc.2023.01.010. Epub 2023 Mar 6. Ann Oncol. 2023. PMID: 36882139
-
European cancer mortality predictions for the year 2020 with a focus on prostate cancer.Ann Oncol. 2020 May;31(5):650-658. doi: 10.1016/j.annonc.2020.02.009. Epub 2020 Apr 19. Ann Oncol. 2020. PMID: 32321669
-
Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996.Lung Cancer. 1997 May;17(1):1-60. doi: 10.1016/s0169-5002(97)00648-x. Lung Cancer. 1997. PMID: 9194026 Review.
-
Epidemiological research on cancer with a focus on Europe.Eur J Cancer Prev. 2003 Feb;12(1):5-14. doi: 10.1097/00008469-200302000-00003. Eur J Cancer Prev. 2003. PMID: 12548105 Review.
Cited by
-
New Regional Dynamic Cancer Model across the European Union.Cancers (Basel). 2023 Apr 28;15(9):2545. doi: 10.3390/cancers15092545. Cancers (Basel). 2023. PMID: 37174011 Free PMC article.
-
αvβ6-integrin targeted PET/CT imaging in pancreatic cancer patients using 68Ga-Trivehexin.Front Nucl Med. 2024 Nov 15;4:1487602. doi: 10.3389/fnume.2024.1487602. eCollection 2024. Front Nucl Med. 2024. PMID: 39618940 Free PMC article.
-
The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants.Fam Cancer. 2024 Aug;23(3):233-246. doi: 10.1007/s10689-024-00397-w. Epub 2024 May 23. Fam Cancer. 2024. PMID: 38780705 Free PMC article.
-
The global, regional burden of pancreatic cancer and its attributable risk factors from 1990 to 2021.BMC Cancer. 2025 Jan 31;25(1):186. doi: 10.1186/s12885-025-13471-y. BMC Cancer. 2025. PMID: 39891086 Free PMC article.
-
Incidence of Diabetes Mellitus and Its Impact on Outcomes in Patients Undergoing Surgical Pancreatectomy for Non-Malignant and Malignant Pancreatobiliary Diseases-A Retrospective Analysis.J Clin Med. 2023 Dec 6;12(24):7532. doi: 10.3390/jcm12247532. J Clin Med. 2023. PMID: 38137600 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical